Japan's Novartis May Become Its GSK As Drug Maker Gifts Questioned
This article was originally published in PharmAsia News
Executive Summary
China has its GlaxoSmithKline, now Japan has its Novartis Pharma KK, which also could expose behavior problems in another medical industry with close relationships with people it relies on for sales.